FdaApplication
ANDA 208295
Identifiers
- fda_app_no: ANDA208295
Properties
| Property | Value |
|---|---|
| applicant_name | WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC |
| application_type | ANDA |
| approval_date | 2019-12-19 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ALVIMOPAN | ALVIMOPAN | 12MG | CAPSULE;ORAL |
1 product